Clinical Trial Update: Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO [NA]

View source ↗

Summary

A terminated clinical trial evaluating fecal microbiota transplantation for dysbiosis and clearance of antimicrobial resistant organisms; results posted in 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antimicrobial Resistant Infection
• Dysbiosis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Vancouver Island Health Authority | Conditions: Dysbiosis, Antimicrobial Resistant Organism | NA | Status: TERMINATED | Results posted: 2024-03-18